NeuroBo Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • NeuroBo Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $151K, a 30.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $151K -$67K -30.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $169K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $186K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $202K Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $218K Sep 30, 2023 10-Q 2023-11-13
Q1 2022 $99K -$24K -19.5% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $105K -$25K -19.2% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $111K +$11K +11% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $117K +$12K +11.4% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $123K -$20K -14% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $130K -$20K -13.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $100K -$26K -20.6% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $105K +$87K +483% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $143K +$99K +225% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 $150K +$141K +1567% Dec 31, 2019 10-K 2021-04-15
Q3 2019 $126K Sep 30, 2019 10-K 2020-03-30
Q2 2019 $18K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $44K Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $9K Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.